Cargando…

Revisiting the guidelines for ending isolation for COVID-19 patients

Since the start of the COVID-19 pandemic, two mainstream guidelines for defining when to end the isolation of SARS-CoV-2-infected individuals have been in use: the one-size-fits-all approach (i.e. patients are isolated for a fixed number of days) and the personalized approach (i.e. based on repeated...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Yong Dam, Ejima, Keisuke, Kim, Kwang Su, Iwanami, Shoya, Bento, Ana I, Fujita, Yasuhisa, Jung, Il Hyo, Aihara, Kazuyuki, Watashi, Koichi, Miyazaki, Taiga, Wakita, Takaji, Iwami, Shingo, Ajelli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/
https://www.ncbi.nlm.nih.gov/pubmed/34311842
http://dx.doi.org/10.7554/eLife.69340
_version_ 1783729777108058112
author Jeong, Yong Dam
Ejima, Keisuke
Kim, Kwang Su
Iwanami, Shoya
Bento, Ana I
Fujita, Yasuhisa
Jung, Il Hyo
Aihara, Kazuyuki
Watashi, Koichi
Miyazaki, Taiga
Wakita, Takaji
Iwami, Shingo
Ajelli, Marco
author_facet Jeong, Yong Dam
Ejima, Keisuke
Kim, Kwang Su
Iwanami, Shoya
Bento, Ana I
Fujita, Yasuhisa
Jung, Il Hyo
Aihara, Kazuyuki
Watashi, Koichi
Miyazaki, Taiga
Wakita, Takaji
Iwami, Shingo
Ajelli, Marco
author_sort Jeong, Yong Dam
collection PubMed
description Since the start of the COVID-19 pandemic, two mainstream guidelines for defining when to end the isolation of SARS-CoV-2-infected individuals have been in use: the one-size-fits-all approach (i.e. patients are isolated for a fixed number of days) and the personalized approach (i.e. based on repeated testing of isolated patients). We use a mathematical framework to model within-host viral dynamics and test different criteria for ending isolation. By considering a fixed time of 10 days since symptom onset as the criterion for ending isolation, we estimated that the risk of releasing an individual who is still infectious is low (0–6.6%). However, this policy entails lengthy unnecessary isolations (4.8–8.3 days). In contrast, by using a personalized strategy, similar low risks can be reached with shorter prolonged isolations. The obtained findings provide a scientific rationale for policies on ending the isolation of SARS-CoV-2-infected individuals.
format Online
Article
Text
id pubmed-8315804
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-83158042021-07-28 Revisiting the guidelines for ending isolation for COVID-19 patients Jeong, Yong Dam Ejima, Keisuke Kim, Kwang Su Iwanami, Shoya Bento, Ana I Fujita, Yasuhisa Jung, Il Hyo Aihara, Kazuyuki Watashi, Koichi Miyazaki, Taiga Wakita, Takaji Iwami, Shingo Ajelli, Marco eLife Microbiology and Infectious Disease Since the start of the COVID-19 pandemic, two mainstream guidelines for defining when to end the isolation of SARS-CoV-2-infected individuals have been in use: the one-size-fits-all approach (i.e. patients are isolated for a fixed number of days) and the personalized approach (i.e. based on repeated testing of isolated patients). We use a mathematical framework to model within-host viral dynamics and test different criteria for ending isolation. By considering a fixed time of 10 days since symptom onset as the criterion for ending isolation, we estimated that the risk of releasing an individual who is still infectious is low (0–6.6%). However, this policy entails lengthy unnecessary isolations (4.8–8.3 days). In contrast, by using a personalized strategy, similar low risks can be reached with shorter prolonged isolations. The obtained findings provide a scientific rationale for policies on ending the isolation of SARS-CoV-2-infected individuals. eLife Sciences Publications, Ltd 2021-07-27 /pmc/articles/PMC8315804/ /pubmed/34311842 http://dx.doi.org/10.7554/eLife.69340 Text en © 2021, Jeong et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Microbiology and Infectious Disease
Jeong, Yong Dam
Ejima, Keisuke
Kim, Kwang Su
Iwanami, Shoya
Bento, Ana I
Fujita, Yasuhisa
Jung, Il Hyo
Aihara, Kazuyuki
Watashi, Koichi
Miyazaki, Taiga
Wakita, Takaji
Iwami, Shingo
Ajelli, Marco
Revisiting the guidelines for ending isolation for COVID-19 patients
title Revisiting the guidelines for ending isolation for COVID-19 patients
title_full Revisiting the guidelines for ending isolation for COVID-19 patients
title_fullStr Revisiting the guidelines for ending isolation for COVID-19 patients
title_full_unstemmed Revisiting the guidelines for ending isolation for COVID-19 patients
title_short Revisiting the guidelines for ending isolation for COVID-19 patients
title_sort revisiting the guidelines for ending isolation for covid-19 patients
topic Microbiology and Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315804/
https://www.ncbi.nlm.nih.gov/pubmed/34311842
http://dx.doi.org/10.7554/eLife.69340
work_keys_str_mv AT jeongyongdam revisitingtheguidelinesforendingisolationforcovid19patients
AT ejimakeisuke revisitingtheguidelinesforendingisolationforcovid19patients
AT kimkwangsu revisitingtheguidelinesforendingisolationforcovid19patients
AT iwanamishoya revisitingtheguidelinesforendingisolationforcovid19patients
AT bentoanai revisitingtheguidelinesforendingisolationforcovid19patients
AT fujitayasuhisa revisitingtheguidelinesforendingisolationforcovid19patients
AT jungilhyo revisitingtheguidelinesforendingisolationforcovid19patients
AT aiharakazuyuki revisitingtheguidelinesforendingisolationforcovid19patients
AT watashikoichi revisitingtheguidelinesforendingisolationforcovid19patients
AT miyazakitaiga revisitingtheguidelinesforendingisolationforcovid19patients
AT wakitatakaji revisitingtheguidelinesforendingisolationforcovid19patients
AT iwamishingo revisitingtheguidelinesforendingisolationforcovid19patients
AT ajellimarco revisitingtheguidelinesforendingisolationforcovid19patients